Cargando…
Subcutaneous Administration of Biotherapeutics: An Overview of Current Challenges and Opportunities
Subcutaneous delivery of biotherapeutics has become a valuable alternative to intravenous administration across many disease areas. Although the pharmacokinetic profiles of subcutaneous and intravenous formulations differ, subcutaneous administration has proven effective, safe, well-tolerated, gener...
Autores principales: | Bittner, Beate, Richter, Wolfgang, Schmidt, Johannes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182494/ https://www.ncbi.nlm.nih.gov/pubmed/30043229 http://dx.doi.org/10.1007/s40259-018-0295-0 |
Ejemplares similares
-
Biotherapeutics: Challenges and Opportunities for Predictive Toxicology of Monoclonal Antibodies
por: Johnson, Dale E.
Publicado: (2018) -
Optimizing the Bioavailability of Subcutaneously Administered Biotherapeutics Through Mechanochemical Drivers
por: Collins, D. S., et al.
Publicado: (2017) -
Intravenous versus subcutaneous delivery of biotherapeutics in IBD: an expert’s and patient’s perspective
por: Jonaitis, Laimas, et al.
Publicado: (2021) -
Machine-designed biotherapeutics: opportunities, feasibility and advantages of deep learning in computational antibody discovery
por: Wilman, Wiktoria, et al.
Publicado: (2022) -
Investigating the Food and Drug Administration Biotherapeutics Review and Approval Process: Narrative Review
por: Bonet Olivencia, Samuel, et al.
Publicado: (2021)